In particle therapy, the uncertainty of the delivered particle range during the patient irradiation limits the optimization of the treatment planning. Therefore, an in vivo treatment verification device is required, not only to improve the plan robustness, but also to detect significant interfractional morphological changes during the treatment itself. In this article, an effective and robust analysis to detect regions with a significant range discrepancy is proposed. This study relies on an in vivo treatment verification by means of in-beam Positron Emission Tomography (PET) and was carried out with the INSIDE system installed at the National Center of Oncological Hadrontherapy (CNAO) in Pavia, which is under clinical testing since July 2019. Patients affected by head-and-neck tumors treated with protons have been considered. First, in order to tune the analysis parameters, a Monte Carlo (MC) simulation was carried out to reproduce a patient who required a replanning because of significant morphological changes found during the treatment. Then, the developed approach was validated on the experimental measurements of three patients recruited for the INSIDE clinical trial (ClinicalTrials.gov ID: NCT03662373), showing the capability to estimate the treatment compliance with the prescription both when no morphological changes occurred and when a morphological change did occur, thus proving to be a promising tool for clinicians to detect variations in the patients treatments.

Detection of Interfractional Morphological Changes in Proton Therapy: A Simulation and In Vivo Study With the INSIDE In-Beam PET / Fiorina, E.; Ferrero, V.; Baroni, G.; Battistoni, G.; Belcari, N.; Camarlinghi, N.; Cerello, P.; Ciocca, M.; De Simoni, M.; Donetti, M.; Dong, Y.; Embriaco, A.; Fischetti, M.; Franciosini, G.; Giraudo, G.; Kraan, A.; Laruina, F.; Luongo, C.; Maestri, D.; Magi, M.; Magro, G.; Malekzadeh, E.; Mancini Terracciano, C.; Marafini, M.; Mattei, I.; Mazzoni, E.; Mereu, P.; Mirabelli, R.; Mirandola, A.; Morrocchi, M.; Muraro, S.; Patera, A.; Patera, V.; Pennazio, F.; Retico, A.; Rivetti, A.; Da Rocha Rolo, M. D.; Rosso, V.; Sarti, A.; Schiavi, A.; Sciubba, A.; Solfaroli Camillocci, E.; Sportelli, G.; Tampellini, S.; Toppi, M.; Traini, G.; Valle, S. M.; Valvo, F.; Vischioni, B.; Vitolo, V.; Wheadon, R.; Bisogni, M. G.. - In: FRONTIERS IN PHYSICS. - ISSN 2296-424X. - 8:(2021). [10.3389/fphy.2020.578388]

Detection of Interfractional Morphological Changes in Proton Therapy: A Simulation and In Vivo Study With the INSIDE In-Beam PET

Ciocca M.;De Simoni M.;Fischetti M.;Franciosini G.;Giraudo G.;Mancini Terracciano C.;Mattei I.;Mirabelli R.;Mirandola A.;Patera A.;Patera V.;Rivetti A.;Sarti A.;Sciubba A.;Solfaroli Camillocci E.;Sportelli G.;Toppi M.;Vitolo V.;
2021

Abstract

In particle therapy, the uncertainty of the delivered particle range during the patient irradiation limits the optimization of the treatment planning. Therefore, an in vivo treatment verification device is required, not only to improve the plan robustness, but also to detect significant interfractional morphological changes during the treatment itself. In this article, an effective and robust analysis to detect regions with a significant range discrepancy is proposed. This study relies on an in vivo treatment verification by means of in-beam Positron Emission Tomography (PET) and was carried out with the INSIDE system installed at the National Center of Oncological Hadrontherapy (CNAO) in Pavia, which is under clinical testing since July 2019. Patients affected by head-and-neck tumors treated with protons have been considered. First, in order to tune the analysis parameters, a Monte Carlo (MC) simulation was carried out to reproduce a patient who required a replanning because of significant morphological changes found during the treatment. Then, the developed approach was validated on the experimental measurements of three patients recruited for the INSIDE clinical trial (ClinicalTrials.gov ID: NCT03662373), showing the capability to estimate the treatment compliance with the prescription both when no morphological changes occurred and when a morphological change did occur, thus proving to be a promising tool for clinicians to detect variations in the patients treatments.
File allegati a questo prodotto
File Dimensione Formato  
Fiorina_Detection_2021.pdf

solo gestori archivio

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 1.97 MB
Formato Adobe PDF
1.97 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1551181
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 7
social impact